Amanote Research
Register
Sign In
Clearance of Psoriasis With Low Dose Cyclosporin.
BMJ
doi 10.1136/bmj.293.6554.1098-c
Full Text
Open PDF
Abstract
Available in
full text
Date
October 25, 1986
Authors
D B Brookes
Publisher
BMJ
Related search
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance
Acta Dermato-Venereologica
Dermatology
Medicine
Antipyrine Clearance in Psoriasis.
BMJ
Cyclosporin a Treatment in Severe Childhood Psoriasis
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
Low-Dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
Cureus
Clinical Experience of Cyclosporin Treatment in Patients With Psoriasis and Psoriatic Arthritis
Journal of Dermatology
Dermatology
Medicine
Optimal Dose of Cyclosporin in Living Related Kidney Transplantation
Japanese Journal of Urology
Urology
Image Gallery: Complete Remission of Aggressive Desmoid-Type Fibromatosis After Low-Dose Methotrexate for 2 Weeks in a Child With Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Fatal, Incidental, Idiopathic Pulmonary Fibrosis in a Patient Receiving Long‐term Low‐dose Methotrexate for Psoriasis
Clinical and Experimental Dermatology
Dermatology
Dose-Creep of Infliximab During Psoriasis Treatment: An Observational Study
Acta Dermato-Venereologica
Dermatology
Medicine